{"id":249895,"date":"2026-09-16T15:39:06","date_gmt":"2026-09-16T10:09:06","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=249895"},"modified":"2026-09-16T15:39:06","modified_gmt":"2026-09-16T10:09:06","slug":"why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/","title":{"rendered":"Glaxosmithkline Pharmaceuticals Ltd. (GLAXO): Glaxosmithkline Pharmaceuticals Share Price Rises 2.34% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO)<\/a> share price rose to Rs 2,880 today, up 2.34% from the previous close. Market cap was Rs 48,063.88 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 16 September 2026 at 3:33:00 PM IST<\/p>\n<p style=\"margin-top:0!important;\">Glaxosmithkline Pharmaceuticals Ltd. share price rose today, with GLAXO Share Price at Rs 2,880, up 2.34% from the previous close of Rs 2,814.1. The company\u2019s market capitalisation stands at Rs 48,063.88 crore, placing the move in a sizeable listed healthcare name. The session\u2019s price rise is clearly verified by the data, but the supplied figures do not establish a company-specific catalyst.<\/p>\n<p>For readers tracking <strong>GLAXO Share Price Today<\/strong>, the move is notable because it came after an opening level of Rs 2,807, a low of Rs 2,758.35 and a high that matched the closing price at Rs 2,880. Turnover stood at Rs 1.41 crore, which is a factual traded-value measure and should be read alongside the day\u2019s price action rather than as a signal by itself. In Univest\u2019s stock news view, the event matters because the stock moved higher on a day when valuation, sector positioning and company fundamentals remain in focus.<\/p>\n<p>From a market-news angle, GLAXO Stock News today is best understood as a verified share price rise, not as a claim-driven story. Univest notes that investors usually look next at the close relative to the day\u2019s range, the company\u2019s earnings quality and how the stock compares with healthcare peers on valuation and profitability. The available data gives enough context for a grounded stock analysis, even without a stated trigger.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#GLAXO_Share_Price_Today_Price_Action_Analysis\" title=\"GLAXO Share Price Today: Price Action Analysis\">GLAXO Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Fundamental_Analysis\" title=\"Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#Why_Investors_Are_Watching_GLAXO\" title=\"Why Investors Are Watching GLAXO\">Why Investors Are Watching GLAXO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#About_Glaxosmithkline_Pharmaceuticals_Ltd\" title=\"About Glaxosmithkline Pharmaceuticals Ltd.\">About Glaxosmithkline Pharmaceuticals Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#Track_GLAXO_Share_Price_on_Univest\" title=\"Track GLAXO Share Price on Univest\">Track GLAXO Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#Why_is_GLAXO_Share_Price_rising_today\" title=\"Why is GLAXO Share Price rising today?\">Why is GLAXO Share Price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#What_is_the_current_GLAXO_Share_Price_Today\" title=\"What is the current GLAXO Share Price Today?\">What is the current GLAXO Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#What_is_GLAXOs_market_capitalisation\" title=\"What is GLAXO\u2019s market capitalisation?\">What is GLAXO\u2019s market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#How_do_GLAXOs_valuation_ratios_look\" title=\"How do GLAXO\u2019s valuation ratios look?\">How do GLAXO\u2019s valuation ratios look?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#What_do_GLAXOs_ROE_and_ROCE_show\" title=\"What do GLAXO\u2019s ROE and ROCE show?\">What do GLAXO\u2019s ROE and ROCE show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#How_does_GLAXO_compare_with_healthcare_peers\" title=\"How does GLAXO compare with healthcare peers?\">How does GLAXO compare with healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-16\/#Should_investors_track_GLAXO_Share_Price_on_Univest\" title=\"Should investors track GLAXO Share Price on Univest?\">Should investors track GLAXO Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"GLAXO_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>GLAXO Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,880<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,814.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 65.9 (+2.34%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,807<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,880<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,758.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.41 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 48,063.88 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) rose to Rs 2,880 from the previous close of Rs 2,814.1, a move of Rs 65.9 or 2.34%. The stock opened at Rs 2,807, reached a high of Rs 2,880, recorded a low of Rs 2,758.35.<\/p>\n<p>GLAXO Share Price Today closed at Rs 2,880 after rising Rs 65.9, or 2.34%, versus the previous close of Rs 2,814.1. The stock opened at Rs 2,807, moved between Rs 2,758.35 and Rs 2,880, and finished at the day\u2019s high. That sequence confirms a clear same-day price rise in a healthcare counter that remained active in the Indian Stock Market narrative today. The turnover of Rs 1.41 crore adds trading context, while the company\u2019s market cap of Rs 48,063.88 crore keeps the move relevant within the broader Share Market Today discussion. For Univest readers, the key point is simple: the stock ended stronger than it began, and the supplied data confirms the size of the move without attaching an unverified reason.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Fundamental_Analysis\"><\/span><strong>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 48,063.88 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.63x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">66.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 63.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 148.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.03%<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) fundamental metrics show P\/E 44.63x, P\/B 18.92x, ROE 48.76%, ROCE 66.79%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. has a market capitalisation of Rs 48063.88 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 44.63x, P\/B at 18.92x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 48.76% and ROCE of 66.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 63.05, book value per share of Rs 148.77, dividend yield of 2.03%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 31.74x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.63x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">47.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.29x to 683.37x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">66.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.65%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 48,063.88 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 750.5 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P\/E ratio of 44.63x, which is above the benchmark median of 31.74x, a difference of +40.61%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROE of 48.76%, which is above the benchmark median of 11.78%, a difference of +313.92%. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROCE of 66.79%, which is above the benchmark median of 13.65%, a difference of +389.3%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,41,957.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,47,576<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,233.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,11,670.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,10,272.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P\/E ratio of 44.63x compared with the displayed peer median of 36.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.76% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 66.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 48,063.88 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_GLAXO\"><\/span><strong>Why Investors Are Watching GLAXO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>GLAXO Share Price rose 2.34% today to Rs 2,880, and the close matched the day\u2019s high.<\/li>\n<li>The company\u2019s market capitalisation stands at Rs 48,063.88 crore, giving the move meaningful listed-company context.<\/li>\n<li>P\/E at 44.63 and P\/B at 18.92 place the stock above several healthcare peers on valuation ratios.<\/li>\n<li>ROE of 48.76% and ROCE of 66.79% are the highest among the supplied peer set.<\/li>\n<li>Turnover of Rs 1.41 crore and the day\u2019s range between Rs 2,758.35 and Rs 2,880 frame the session\u2019s price action.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Glaxosmithkline_Pharmaceuticals_Ltd\"><\/span><strong>About Glaxosmithkline Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glaxosmithkline Pharmaceuticals Ltd. is part of the Healthcare sector and the Pharmaceuticals &#038; Drugs industry. The company is listed on the NSE and BSE under the symbol GLAXO. Based on the supplied data, the stock is tracked in the Indian pharmaceutical space alongside companies such as Sun Pharma, Divi\u2019s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. That makes GLAXO Stock News relevant not only for the day\u2019s share price rise, but also for broader sector comparison.<\/p>\n<p>The company\u2019s financial profile in the supplied data suggests a business with strong earnings and capital-return ratios, with EPS at Rs 63.05, book value at Rs 148.77 and dividend yield at 2.03%. Those figures help frame the GLAXO Share Price beyond one trading session. Investors using Univest for company news and stock analysis can place the stock within healthcare fundamentals, valuation and peer context rather than looking at the day\u2019s move in isolation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_GLAXO_Share_Price_on_Univest\"><\/span><strong>Track GLAXO Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Readers can track GLAXO Share Price on Univest for live share price updates, company news, fundamental ratios, shareholding pattern, market cap, 52-week levels and market insights. Univest also presents GLAXO share price today in a format that helps users connect the day\u2019s move with valuation, sector performance and listed peer comparison.<\/p>\n<p>For users following GLAXO Latest News, Univest is designed to keep the stock in one place with a clean stock-detail view, helping readers check the share price rise, review company financials and compare the name with other healthcare companies.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_GLAXO_Share_Price_rising_today\"><\/span><strong>Why is GLAXO Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO Share Price rose 2.34% today to Rs 2,880. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind the move. The previous close was Rs 2,814.1.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_GLAXO_Share_Price_Today\"><\/span><strong>What is the current GLAXO Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO Share Price Today is Rs 2,880. It is Rs 65.9 above the previous close of Rs 2,814.1, and the day\u2019s move reflects a verified same-session gain. The previous close was Rs 2,814.1.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_GLAXOs_market_capitalisation\"><\/span><strong>What is GLAXO\u2019s market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO has a market capitalisation of Rs 48,063.88 crore. That places the company well above the industry median in the supplied benchmark and supports its standing in healthcare comparisons. The company operates in the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_GLAXOs_valuation_ratios_look\"><\/span><strong>How do GLAXO\u2019s valuation ratios look?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO trades at a P\/E of 44.63 and a P\/B of 18.92. Both ratios are above several supplied peers and sit above the industry median, which frames the valuation discussion.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_GLAXOs_ROE_and_ROCE_show\"><\/span><strong>What do GLAXO\u2019s ROE and ROCE show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO reports ROE of 48.76% and ROCE of 66.79%. These are strong absolute readings in the supplied data and exceed the benchmark medians for the same industry set. ROE stands at 48.76%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_GLAXO_compare_with_healthcare_peers\"><\/span><strong>How does GLAXO compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO\u2019s ROE and ROCE are higher than the supplied peer set, while its P\/E sits between lower-multiple and higher-multiple pharma names. That creates a mixed but clearly defined peer position.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_track_GLAXO_Share_Price_on_Univest\"><\/span><strong>Should investors track GLAXO Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Univest lets readers track GLAXO Share Price, company news, market cap, valuation ratios, shareholding pattern and healthcare sector context in one place for a fuller stock analysis view. The previous close was Rs 2,814.1.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glaxosmithkline Pharmaceuticals Ltd. Share Price rises to Rs 2,880. marking a 2.34% rise today. Market cap stands at Rs 48,063.88 crore.<\/p>\n","protected":false},"author":29,"featured_media":249894,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-249895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["249894"],"rank_math_title":["GLAXO Share Price Rises 2.34%: Valuation View"],"rank_math_description":["GLAXO Share Price rose 2.34% to Rs 2,880 today. Read the price action, valuation, peer context, sector view and company fundamentals."],"rank_math_focus_keyword":["GLAXO Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Glaxosmithkline_Pharmaceuticals_Share_Price_Rises_234_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/249895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=249895"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/249895\/revisions"}],"predecessor-version":[{"id":249896,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/249895\/revisions\/249896"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/249894"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=249895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=249895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=249895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}